Cargando…
Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments
Neoplastic meningitis (NM) is a devastating complication of solid tumors with poor outcome. Some randomized clinical trials have been conducted with heterogeneous inclusion criteria, diagnostic parameters, response evaluation and primary endpoints. Recently, the Leptomeningeal Assessment in Neuro-On...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844521/ https://www.ncbi.nlm.nih.gov/pubmed/29535794 http://dx.doi.org/10.1177/1756286418759618 |
_version_ | 1783305247912886272 |
---|---|
author | Pellerino, Alessia Bertero, Luca Rudà, Roberta Soffietti, Riccardo |
author_facet | Pellerino, Alessia Bertero, Luca Rudà, Roberta Soffietti, Riccardo |
author_sort | Pellerino, Alessia |
collection | PubMed |
description | Neoplastic meningitis (NM) is a devastating complication of solid tumors with poor outcome. Some randomized clinical trials have been conducted with heterogeneous inclusion criteria, diagnostic parameters, response evaluation and primary endpoints. Recently, the Leptomeningeal Assessment in Neuro-Oncology (LANO) Group and the European Society for Medical Oncology/European Association for Neuro-Oncology have proposed some recommendations in order to provide diagnostic criteria and response evaluation scores for NM. The aim of these guidelines is to integrate the neurological examination with magnetic resonance imaging and cerebrospinal fluid findings as well as to provide a framework for use in clinical trials. However, this composite assessment needs further validation. Since intrathecal therapy represents a treatment with limited efficacy in NM, many studies have been conducted on systemic therapies, including target therapies, with some encouraging results in terms of disease control. In this review, we have analyzed the clinical aspects and the most recent diagnostic tools and therapeutic options in NM. |
format | Online Article Text |
id | pubmed-5844521 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-58445212018-03-13 Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments Pellerino, Alessia Bertero, Luca Rudà, Roberta Soffietti, Riccardo Ther Adv Neurol Disord Review Neoplastic meningitis (NM) is a devastating complication of solid tumors with poor outcome. Some randomized clinical trials have been conducted with heterogeneous inclusion criteria, diagnostic parameters, response evaluation and primary endpoints. Recently, the Leptomeningeal Assessment in Neuro-Oncology (LANO) Group and the European Society for Medical Oncology/European Association for Neuro-Oncology have proposed some recommendations in order to provide diagnostic criteria and response evaluation scores for NM. The aim of these guidelines is to integrate the neurological examination with magnetic resonance imaging and cerebrospinal fluid findings as well as to provide a framework for use in clinical trials. However, this composite assessment needs further validation. Since intrathecal therapy represents a treatment with limited efficacy in NM, many studies have been conducted on systemic therapies, including target therapies, with some encouraging results in terms of disease control. In this review, we have analyzed the clinical aspects and the most recent diagnostic tools and therapeutic options in NM. SAGE Publications 2018-03-07 /pmc/articles/PMC5844521/ /pubmed/29535794 http://dx.doi.org/10.1177/1756286418759618 Text en © The Author(s), 2018 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Review Pellerino, Alessia Bertero, Luca Rudà, Roberta Soffietti, Riccardo Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments |
title | Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments |
title_full | Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments |
title_fullStr | Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments |
title_full_unstemmed | Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments |
title_short | Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments |
title_sort | neoplastic meningitis in solid tumors: from diagnosis to personalized treatments |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844521/ https://www.ncbi.nlm.nih.gov/pubmed/29535794 http://dx.doi.org/10.1177/1756286418759618 |
work_keys_str_mv | AT pellerinoalessia neoplasticmeningitisinsolidtumorsfromdiagnosistopersonalizedtreatments AT berteroluca neoplasticmeningitisinsolidtumorsfromdiagnosistopersonalizedtreatments AT rudaroberta neoplasticmeningitisinsolidtumorsfromdiagnosistopersonalizedtreatments AT soffiettiriccardo neoplasticmeningitisinsolidtumorsfromdiagnosistopersonalizedtreatments |